IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis

Abstract Background Methotrexate (MTX) is the standard first-line therapy in rheumatoid arthritis (RA) with variable clinical efficacy that is difficult to predict. The glycosylation status of immunoglobulin G (IgG) is altered in RA and influenced by MTX treatment. We aimed to further investigate if...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Susanna L. Lundström, Aase H. Hensvold, Dorothea Rutishauser, Lars Klareskog, A. Jimmy Ytterberg, Roman A. Zubarev, Anca I. Catrina
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2017-08-01
Serija:	Arthritis Research & Therapy
Teme:	Immunoglobulin Glycosylation Rheumatoid arthritis Methotrexate Complement Biomarker
Online dostop:	http://link.springer.com/article/10.1186/s13075-017-1389-7
Oznake:	Označite Brez oznak, prvi označite!